Humankind US Stock ETF Rating $34.08 -0.01 (-0.03%) Closing price 08/26/2025 04:10 PM EasternExtended Trading$34.08 +0.01 (+0.01%) As of 08/26/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Humankind US Stock ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HKND Aggregate RatingModerate Buy 2.61Holdings in HKND have an aggregate rating of Moderate Buy based on 509 analyst ratings issued in the past year covering 25 companies (43.4% of the portfolio).HKND Aggregate Price Target$34.08High Prediction$34.08Average Prediction$34.08Low Prediction$34.08Holdings in HKND have an aggregate price target of $34.08 and a range of $34.08 to $34.08 covering 25 companies (43.4% of the portfolio).HKND Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Humankind US Stock ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 HKND Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.47%GOOGLAlphabet$207.14-0.6%3.9073 of 5 stars2.86$211.53 2.1%43Trending News3.50%ADMArcher Daniels Midland$62.89-2.1%4.17 of 5 stars2.00$55.50 -11.7%8Positive News2.57%MSFTMicrosoft$502.04-0.4%4.91 of 5 stars2.97$612.54 22.0%32Trending NewsAnalyst Revision2.39%JNJJohnson & Johnson$176.63-1.0%4.8735 of 5 stars2.65$176.29 -0.2%20Trending NewsOptions Volume2.33%AAPLApple$229.31+0.9%4.5349 of 5 stars2.57$237.01 3.4%30Trending NewsAnalyst Forecast2.31%ABBVAbbVie$208.51+0.5%4.6978 of 5 stars2.96$214.95 3.1%27Trending NewsAnalyst Forecast2.19%LLYEli Lilly and Company$734.93+5.7%4.9993 of 5 stars2.70$950.17 29.3%23Trending NewsGap Up2.06%BGBunge Global$85.09-3.5%4.4885 of 5 stars2.50$85.33 0.3%6Positive News1.58%PGProcter & Gamble$155.97-0.1%4.6717 of 5 stars2.68$175.94 12.8%19Positive News1.54%PFEPfizer$24.97-0.7%4.8757 of 5 stars2.39$28.12 12.6%18Trending News1.54%DEDeere & Company$488.59+0.1%4.1499 of 5 stars2.56$523.87 7.2%18Trending NewsAnalyst Upgrade1.47%INTCIntel$24.35-0.8%3.3217 of 5 stars1.86$22.17 -9.0%28Trending News1.43%BDXBecton, Dickinson and Company$193.98-0.3%4.2391 of 5 stars2.36$211.44 9.0%11Positive News1.43%MRKMerck & Co., Inc.$85.14-0.2%4.997 of 5 stars2.35$107.44 26.2%20Positive News1.40%ABTAbbott Laboratories$131.59-0.2%4.9017 of 5 stars2.91$144.47 9.8%22Positive News1.32%TMOThermo Fisher Scientific$488.93-0.4%4.9576 of 5 stars2.73$593.00 21.3%22Positive NewsInsider Trade1.28%GEHCGE HealthCare Technologies$74.09-0.7%3.5365 of 5 stars2.73$88.55 19.5%11Positive News1.24%MOSMosaic$33.30+0.5%4.674 of 5 stars2.79$36.42 9.4%14Positive News1.21%SYKStryker$394.67+1.0%4.447 of 5 stars2.79$430.10 9.0%19Positive News1.15%AMGNAmgen$289.58+0.4%4.7394 of 5 stars2.33$304.43 5.1%21Trending NewsAnalyst Forecast1.05%GILDGilead Sciences$114.75+0.5%4.9836 of 5 stars2.88$115.39 0.6%26Positive News1.05%CTVACorteva$73.90+0.4%4.3079 of 5 stars2.87$80.25 8.6%15Positive News1.02%LHLabcorp$278.41+0.8%4.6578 of 5 stars2.62$290.33 4.3%13Positive NewsAnalyst Forecast0.94%BMYBristol Myers Squibb$47.25+0.2%4.7753 of 5 stars2.24$56.38 19.3%210.93%CVSCVS Health$71.57+0.5%4.9628 of 5 stars3.05$77.56 8.4%22Analyst Forecast This page (NYSEARCA:HKND) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humankind US Stock ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Humankind US Stock ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access